Actym Therapeutics Expands Management Team with Key Appointments to Build Product Pipeline and Advance Clinical Development Strategies
Mary J. Janatpour, PhD, joins Actym as Chief Scientific Officer focused on expanding Actym’s pipeline Shouryadeep “Deep” Srivastava, MD, PhD, joins Actym as Senior Vice President of Clinical Development, leading Actym’s clinical activities BERKELEY, CA — June 25, 2024 Actym Therapeutics, pioneering a new drug modality to treat solid tumors, announced today the appointments of […]
This article is featured on another website.
US FDA Regulatory Meetings
Understanding the various types of regulatory meetings available with the US FDA is crucial for…
US FDA Regulatory Meetings
Understanding the various types of regulatory meetings available with the US FDA is crucial for…
Maximizing Global Study Value: Clinical Trial Landscapes in South Korea and Japan
Clinical trial globalization continues to be a major trend for industry-sponsored clinical trials. More recently,…
Maximizing Global Study Value: Clinical Trial Landscapes in South Korea and Japan
Clinical trial globalization continues to be a major trend for industry-sponsored clinical trials. More recently,…